Page 108 - 82_ex2

450 (7166): 6-9.
26. André J, Scheen AJ, Paquot N. Obesity: A new paradigm
for treating obesity and diabetes mellitus. Nat Rev
Endocrinol 2015; 11: 196-8.
27. Hill JW, Elias CF, Fukuda M et al. Direct insulin and
leptin action in pro-opiomelanocortin neurons is
required for normal glucose homeostasis and fertility.
Cell Metab 2010; 4: 286-97.
28. Friedman JM, Halaas JL. Leptin and the regulation of
body weight in mammals. Nature 1998; 395: 763-70.
29. Perianes-Cachero A, Burgos-Ramos E, Puebla-Jiménez
L et al. Acute up-regulation of the rat brain
somatostatin receptor-effector system by leptin is
related to activation of insulin signaling and may
counteract central leptin actions. Neuroscience 2013;
252: 289-301.
30. Soedling H, Hodson DJ, Adrianssens AE et al. Limited
impact on glucose homeostasis of leptin receptor
deletion from insulin- or proglucagon-expressing
cells. Mol Metab 2015; 4: 619-30.
31. Burgos-Ramos E, Chowen JA, Arilla-Ferreiro E, et al.
Chronic central leptin infusion modifies the response
to acute central insulin injection by reducing the
interaction of the insulin receptor with IRS2 and
increasing its association with SOCS3. J Neurochem
2011; 117: 175-85.
32. Hillman JB. Ghrelin biology and its role in weight-
related disorders. Discov Med 2011; 11:521-8.
33. Docanto MM, Yang F, Callaghan B, et al. Ghrelin and
des-acyl ghrelin inhibit aromatase expression and
activity in human adipose stromal cells: suppression
of cAMP as a possible mechanism. Breast Cancer Res
Treat 2014; 147: 193-201.
34. Callaghan B, Furness, JB. Novel and conventional
receptors for ghrelin, desacyl-ghrelin, and
pharmacologically related compounds.
Pharmacological Rev 2014; 66: 984-1001.
35. Broad J, Callaghan B, Sanger GJ, et al. Analysis of
the ghrelin receptor-independent vascular actions of 56. Aguilera CM, Gil-Campos M, Cañete R, Gil A.
ulimorelin. Eur J Pharmacol 2015; 14752C: 34-9.
36. Attie AD, Scherer PE. Adipocyte metabolism and
obesity. J Lipid Res 2009; 50: S395-9.
37. Lafontan M. Adipose tissue and adipocyte
dysregulation. Diabetes Metab 2014; 40: 16-28.
38. Pedersen DJ, Guilherme A, Danai LV et al. A major
role of insulin in promoting obesity-associated
adipose tissue inflammation. Mol Metab 2015; 4: 507-
18.
39. Saponaro C, Gaggini M, Carli F, Gastaldelli A. The
subtle balance between lipolysis and lipogenesis: A
critical point in metabolic homeostasis. Nutrients
2015; 7: 9453-74.
40. Kersten S. Mechanisms of nutritional and hormonal
regulation of lipogenesis. EMBO Rep 2001; 2: 282-6.
41. Scherer T, O’Hare J, Diggs-Andrews K, et al. Brain
insulin controls adipose tissue lipolysis and
104
Evangelina Palacios Alaiz
lipogenesis. Cell Metabol 2011; 13: 183-94.
42. McTernan PG, Harte AL, Anderson LA, et al. Insulin
and rosiglitazone regulation of lipolysis and
lipogenesis in human adipose tissue in vitro. Diabetes
2002; 51: 1493-8.
43. Gathercole LL, Morgan SA, Bujalska IJ, et al.
Regulation of lipogenesis by glucocorticoids and
insulin in human adipose tissue. PLoS One 2011;
6(10): e26223.
44. Czech MP, Tencerova M, Pedersen DJ, Aouadi M.
Insulin signaling mechanisms for triacylglycerol
storage. Diabetologia 2013; 56: 949-64.
45. Boden, G; Salehi, S.; Cheung, P, et al. Comparison of
in vivo effects of insulin on SREBP-1c activation and
INSIG-1/2 in rat liver and human and rat adipose
tissue. Obesity 2013; 21: 1208-14.
46. Herman MA; Peroni OD; Villoria J, et al. A novel
chREBP isoform in adipose tissue regulates systemic
glucose metabolism. Nature 2012; 484: 333-8.
47. Nielsen TS, Jessen N, Jørgensen JO, Møller N, Lund S.
Dissecting adipose tissue lipolysis: molecular
regulation and implications for metabolic disease. J
Mol Endocrinol 2014; 52: R199-222.
48. Tang Y, Wallace M, Sanchez-Gurmaches J, Hsiao
WY, Li H, Lee PL, Vernia S, Metallo CM, Guertin
DA. Adipose tissue mTORC2 regulates ChREBP-
driven de novo lipogenesis and hepatic glucose
metabolism. Nat Commun 2016; 7: 11365.
49. Girousse A, Tavernier G, Valle C, et al. Partial
inhibition of adipose tissue lipolysis improves glucose
metabolism and insulin sensitivity without alteration
of fat mass. PLoS Biol 2013; 11(2): e1001485.
50. Morton GJ. Hypothalamic leptin regulation of energy
homeostasis and glucose metabolism. J Physiol 2007;
583: 437-43.
51. Münzberg H, Morrison CD. Structure, production and
signaling of leptin. Metabolism 2015; 64(1): 13-23.
52. Sainz N; Barrenetxe J; Moreno-Aliaga MJ, et al.
Leptin resistance and diet-induced obesity: Central
and peripheral actions of leptin. Metabolism 2015; 64:
35-46.
53. Morris DL, Rui L. Recent advances in understanding
leptin signaling and leptin resistance. Am J Physiol
Endocrinol Metab 2009; 297: E1247-59.
54. Domingos PLB, Farias LC, Pereira CS, et al. Leptin
receptor polymorphism Gln223Arg (rs1137101) in
oral squamous cell carcinoma and potentially
malignant oral lesions. SpringerPlus 2014; 3: 683.
55. Wolsk E, Mygind H, Grøndahl TS, Pedersen BK, van
Hall G. The role of leptin in human lipid and glucose
metabolism: the effects of acute recombinant human
leptin infusion in young healthy males. Am J Clin
Nutr 2011; 94:1533-44.
Alterations in plasma and tissue lipids associated with
obesity and metabolic syndrome. Clin Sci 2008; 114:
@Real Academia Nacional de Farmacia. Spain